Works by Calvisi, Diego
Results: 89
[(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01412
- By:
- Publication type:
- Article
Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats.
- Published in:
- Archives of Physiology & Biochemistry, 2009, v. 115, n. 2, p. 97, doi. 10.1080/13813450902870457
- By:
- Publication type:
- Article
Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 11, p. 2410, doi. 10.1002/ijc.22940
- By:
- Publication type:
- Article
Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats.
- Published in:
- International Journal of Cancer, 2004, v. 111, n. 1, p. 9, doi. 10.1002/ijc.20225
- By:
- Publication type:
- Article
Phenotypic reversion of rat neoplastic liver nodules is under genetic control.
- Published in:
- International Journal of Cancer, 2003, v. 105, n. 1, p. 70, doi. 10.1002/ijc.11044
- By:
- Publication type:
- Article
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 6, p. 1, doi. 10.1038/s41419-024-06839-8
- By:
- Publication type:
- Article
Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 7, p. 1, doi. 10.1038/s41419-023-05958-y
- By:
- Publication type:
- Article
Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 10, p. 1, doi. 10.1038/s41419-021-04206-5
- By:
- Publication type:
- Article
Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 2, p. 1, doi. 10.1038/s41419-021-03488-z
- By:
- Publication type:
- Article
Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 2, p. 1, doi. 10.1038/s41419-020-2289-3
- By:
- Publication type:
- Article
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 2, p. 1, doi. 10.1038/s41419-019-1389-4
- By:
- Publication type:
- Article
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 2, p. 1, doi. 10.1038/s41419-017-0183-4
- By:
- Publication type:
- Article
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02394-2
- By:
- Publication type:
- Article
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02283-8
- By:
- Publication type:
- Article
Liver proliferation: The GUCD1/NEDD4-1 connection.
- Published in:
- Cell Cycle, 2014, v. 13, n. 13, p. 2022, doi. 10.4161/cc.29535
- By:
- Publication type:
- Article
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis.
- Published in:
- Cell Cycle, 2013, v. 12, n. 13, p. 1999, doi. 10.4161/cc.25099
- By:
- Publication type:
- Article
CDK9 is dispensable for YAP-driven hepatoblastoma development.
- Published in:
- 2020
- By:
- Publication type:
- journal article
MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma.
- Published in:
- Toxicological Sciences, 2025, v. 203, n. 1, p. 41, doi. 10.1093/toxsci/kfae126
- By:
- Publication type:
- Article
A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01513-5
- By:
- Publication type:
- Article
NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
- Published in:
- Journal of Cell Biology, 2015, v. 208, n. 6, p. 777, doi. 10.1083/jcb.201408087
- By:
- Publication type:
- Article
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges.
- Published in:
- Biomedicines, 2024, v. 13, n. 7, p. 1624, doi. 10.3390/biomedicines12071624
- By:
- Publication type:
- Article
Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 8, p. 1270, doi. 10.3390/jpm12081270
- By:
- Publication type:
- Article
Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice.
- Published in:
- Oncogene, 2005, v. 24, n. 54, p. 8003, doi. 10.1038/sj.onc.1208940
- By:
- Publication type:
- Article
Long-term dehydroepiandrosterone and 16α-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats.
- Published in:
- Carcinogenesis, 2001, v. 22, n. 2, p. 301, doi. 10.1093/carcin/22.2.301
- By:
- Publication type:
- Article
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosamine in the resistant BFF1 rat strain.
- Published in:
- Carcinogenesis, 1999, v. 20, n. 7, p. 1363, doi. 10.1093/carcin/20.7.1363
- By:
- Publication type:
- Article
Current challenges to underpinning the genetic basis for cholangiocarcinoma.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2021, v. 15, n. 5, p. 511, doi. 10.1080/17474124.2021.1915128
- By:
- Publication type:
- Article
RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 5, p. 1091, doi. 10.1002/1878-0261.13135
- By:
- Publication type:
- Article
Molecular Mechanisms of Hepatocarcinogenesis in Transgenic Mouse Models of Liver Cancer.
- Published in:
- Toxicologic Pathology, 2005, v. 33, n. 1, p. 181, doi. 10.1080/01926230590522095
- By:
- Publication type:
- Article
Focal adhesion kinase activation limits efficacy of Dasatinib in c‐Myc driven hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 12, p. 6170, doi. 10.1002/cam4.1777
- By:
- Publication type:
- Article
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 3, p. 409, doi. 10.3390/cells11030409
- By:
- Publication type:
- Article
Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout Mice.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2787, doi. 10.3390/cells10102787
- By:
- Publication type:
- Article
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02536-6
- By:
- Publication type:
- Article
Functional role of SGK3 in PI3K/Pten driven liver tumor development.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 479, n. 1, p. 97, doi. 10.1007/s00428-020-03014-0
- By:
- Publication type:
- Article
Nuclear ErbB2 expression in hepatocytes in liver disease.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 478, n. 2, p. 309, doi. 10.1007/s00428-020-02871-z
- By:
- Publication type:
- Article
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11577-9
- By:
- Publication type:
- Article
Cholangiocarcinoma: State‐of‐the‐art knowledge and challenges.
- Published in:
- Liver International, 2019, v. 39, p. 5, doi. 10.1111/liv.14101
- By:
- Publication type:
- Article
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.
- Published in:
- Liver International, 2019, v. 39, p. 79, doi. 10.1111/liv.14094
- By:
- Publication type:
- Article
The complex role of bone morphogenetic protein 9 in liver damage and regeneration: New evidence from in vivo and in vitro studies.
- Published in:
- Liver International, 2018, v. 38, n. 9, p. 1547, doi. 10.1111/liv.13925
- By:
- Publication type:
- Article
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells.
- Published in:
- Liver International, 2017, v. 37, n. 1, p. 80, doi. 10.1111/liv.13183
- By:
- Publication type:
- Article
Activated mutant forms of PIK3 CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/ mTORC1 cascade.
- Published in:
- Liver International, 2016, v. 36, n. 8, p. 1176, doi. 10.1111/liv.13055
- By:
- Publication type:
- Article
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
- Published in:
- Scientific Reports, 2016, p. 20484, doi. 10.1038/srep20484
- By:
- Publication type:
- Article
Transgenic mouse model expressing P53<sup>R172H</sup>, luciferase, EGFP, and KRAS<sup>G12D</sup> in a single open reading frame for live imaging of tumor.
- Published in:
- Scientific Reports, 2015, p. 8053, doi. 10.1038/srep08053
- By:
- Publication type:
- Article
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury.
- Published in:
- Annals of Gastroenterology, 2018, v. 31, n. 5, p. 552, doi. 10.20524/aog.2018.0288
- By:
- Publication type:
- Article